Profil
Jacob Licht currently works at Exo-Top, Inc., as Chief Executive Officer from 2025 and NurExone Biologic, Inc., as Vice President-Corporate Development from 2025.
Mr. Licht also formerly worked at Emergent BioSolutions, Inc., as Vice President-Corporate Development from 2007 to 2017, Lantheus Medical Imaging, Inc., as Vice President-Business Development from 2021 to 2023, and Bavarian Nordic A, as Vice President-Corporate Development from 2019 to 2021.
Aktiva positioner av Jacob Licht
| Företag | Position | Start |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Företagsledare/Principal | 2025-04-22 |
Tidigare kända positioner av Jacob Licht
| Företag | Position | Slut |
|---|---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Företagsledare/Principal | 2023-04-01 |
| BAVARIAN NORDIC A/S | Företagsledare/Principal | 2021-03-01 |
| EMERGENT BIOSOLUTIONS INC. | Företagsledare/Principal | 2017-04-01 |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Develops and manufactures radio diagnostics | Health Technology |
Bavarian Nordic A/S
Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
NurExone Biologic, Inc.
NurExone Biologic, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
















